1. Home
  2. PRTA vs TIXT Comparison

PRTA vs TIXT Comparison

Compare PRTA & TIXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTA
  • TIXT
  • Stock Information
  • Founded
  • PRTA 2012
  • TIXT 2005
  • Country
  • PRTA Ireland
  • TIXT Canada
  • Employees
  • PRTA N/A
  • TIXT N/A
  • Industry
  • PRTA Biotechnology: Pharmaceutical Preparations
  • TIXT EDP Services
  • Sector
  • PRTA Health Care
  • TIXT Technology
  • Exchange
  • PRTA Nasdaq
  • TIXT Nasdaq
  • Market Cap
  • PRTA 809.8M
  • TIXT 689.4M
  • IPO Year
  • PRTA N/A
  • TIXT 2021
  • Fundamental
  • Price
  • PRTA $9.70
  • TIXT $2.44
  • Analyst Decision
  • PRTA Buy
  • TIXT Hold
  • Analyst Count
  • PRTA 9
  • TIXT 8
  • Target Price
  • PRTA $54.57
  • TIXT $4.69
  • AVG Volume (30 Days)
  • PRTA 605.6K
  • TIXT 272.5K
  • Earning Date
  • PRTA 05-07-2025
  • TIXT 05-09-2025
  • Dividend Yield
  • PRTA N/A
  • TIXT N/A
  • EPS Growth
  • PRTA N/A
  • TIXT N/A
  • EPS
  • PRTA N/A
  • TIXT N/A
  • Revenue
  • PRTA $135,157,000.00
  • TIXT $2,658,000,000.00
  • Revenue This Year
  • PRTA N/A
  • TIXT $3.72
  • Revenue Next Year
  • PRTA $131.71
  • TIXT $3.63
  • P/E Ratio
  • PRTA N/A
  • TIXT N/A
  • Revenue Growth
  • PRTA 47.92
  • TIXT N/A
  • 52 Week Low
  • PRTA $9.00
  • TIXT $2.13
  • 52 Week High
  • PRTA $25.42
  • TIXT $8.49
  • Technical
  • Relative Strength Index (RSI)
  • PRTA 34.03
  • TIXT 42.86
  • Support Level
  • PRTA $9.00
  • TIXT $2.37
  • Resistance Level
  • PRTA $10.07
  • TIXT $2.59
  • Average True Range (ATR)
  • PRTA 0.74
  • TIXT 0.15
  • MACD
  • PRTA 0.07
  • TIXT 0.03
  • Stochastic Oscillator
  • PRTA 28.00
  • TIXT 67.39

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

About TIXT TELUS International (Cda) Inc. Subordinate Voting Shares

TELUS International (Cda) Inc is a digital customer experience innovator that designs, builds, and delivers next-generation solutions. Its clients include companies across several verticals, including Tech and Games, eCommerce and FinTech, Banking, Financial Services and Insurance, Communications and Media, and Healthcare. The solutions offered by the company include Digital Experience, Customer Experience, Advisory Services, and Back Office and Automation among other services. Geographically, it derives a majority of its revenue from the European region.

Share on Social Networks: